Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 16;20(Suppl 3):21668.
doi: 10.7448/IAS.20.4.21668.

Where do HIV-infected adolescents go after transfer? - Tracking transition/transfer of HIV-infected adolescents using linkage of cohort data to a health information system platform

Affiliations

Where do HIV-infected adolescents go after transfer? - Tracking transition/transfer of HIV-infected adolescents using linkage of cohort data to a health information system platform

Mary-Ann Davies et al. J Int AIDS Soc. .

Abstract

Introduction: To evaluate long-term outcomes in HIV-infected adolescents, it is important to identify ways of tracking outcomes after transfer to a different health facility. The Department of Health (DoH) in the Western Cape Province (WCP) of South Africa uses a single unique identifier for all patients across the health service platform. We examined adolescent outcomes after transfer by linking data from four International epidemiology Databases to Evaluate AIDS Southern Africa (IeDEA-SA) cohorts in the WCP with DoH data.

Methods: We included adolescents on antiretroviral therapy who transferred out of their original cohort from 10 to 19 years of age between 2004 and 2014. The DoH conducted the linkage separately for each cohort and linked anonymized data were then combined. The primary outcome was successful transfer defined as having a patient record at a facility other than the original facility after the transfer date. Secondary outcomes included the proportion of patients retained, with HIV-RNA <400 copies/ml and CD4 > 500 cells/µl at 1, 2 and 3 years post-transfer.

Results: Of 460 adolescents transferred out (53% female), 72% transferred at 10-14 years old, and 79% transferred out of tertiary facilities. Overall, 81% of patients transferred successfully at a median (interquartile range) of 56 (27-134) days following transfer date; 95% reached the transfer site <18 months after transfer out. Among those transferring successfully, the proportion retained decreased from 1 to 3 years post-transfer (90-84%). There was no significant difference between transfer and 1-3 years post-transfer in the proportion of retained adolescents with HIV-RNA <400 copies/ml and CD4 > 500 cells/µl except for HIV-RNA <400 copies/ml at 3 years (86% vs. 75%; p = 0.007). The proportion virologically suppressed and with CD4 > 500 cells/µl was significantly lower at 1 and 2 years post-transfer in those transferring at 15-19 vs. 10-14 years of age. Using laboratory data alone over-estimated time to successful transfer.

Conclusions: Linking cohort data to health information system data allowed efficient assessment of post-transfer outcomes. Although >80% of adolescents transferred successfully with nearly 85% of them retained for 3 years post-transfer, the decline in the proportion virologically suppressed and poorer outcomes in older adolescents are concerns.​.

Keywords: HIV-1; adolescents; antiretroviral; data linkage; sub-Saharan Africa; transfer; transition.

PubMed Disclaimer

Conflict of interest statement

All authors have no conflicts of interest to declare.

Figures

Figure 1.
Figure 1.
Sharing a unique health identifier (PMI) to enable subsequent linkage of patient data across multiple domains.
Figure 2.
Figure 2.
a) Per cent of all children successfully transferred and retained at 12, 24 and 36 months after successful transfer and percent with HIV-RNA <400 copies/ml and CD4 > 500 cells/µl among those retained. b) Per cent of all children successfully transferred and retained at 12, 24 and 36 months after successful transfer according to age group at transfer (10-14 years [solid bars] and 15-19 years [diagonal striped bars]). Percent with HIV-RNA <400 copies/ml and CD4 > 500 cells/µl among those retained. P-values comparing outcomes in each age group using chi2 tests are shown on the graph.
None

References

    1. UNAIDS AIDSinfo Online Database [cited 2016. July 1]. Available from http://www.aidsinfoonline.org/devinfo/libraries/aspx/Home.aspx
    1. Johnson L, Davies M, Moultrie H, Sherman G, Bland R, Rehle T, et al. The effect of early initiation of antiretroviral treatment in infants on pediatric AIDS mortality in South Africa - A model-based analysis. Pediatr Infect Dis J. 2012;31:474–24. - PubMed
    1. Maskew M, Bor J, MacLeod W, Carmona S, Sherman G, Fox MP.. The youth treatment bulge in South Africa: increasing numbers, inferior outcomes among adolescents on ART. International AIDS Conference Durban South Africa; 2016.
    1. Evans D, Menezes C, Mahomed K, Macdonald P, Untiedt S, Levin L, et al. Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa. AIDS Res Hum Retroviruses. 2013;29:892–900. - PMC - PubMed
    1. Lamb MR, Fayorsey R, Nuwagaba-Biribonwoha H, Viola V, Mutabazi V, Alwar T, et al. High attrition before and after ART initiation among youth (15-24 years of age) enrolled in HIV care. Aids. 2014;28:559–68. - PMC - PubMed

Substances

LinkOut - more resources